BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia

Neuropsychopharmacology

Volumn 33, Issue 9, 2008, Pages 2200-2205

  Zhang, Xiang Yang ^a,b,c   Zhou, Dong Feng ^b   Wu, Gui Ying ^a,c   Cao, Lian Yuan ^c   Tan, Yun Long ^c   Haile, Colin N ^a   Li, Jun ^d   Lu, Lin ^e   Kosten, Therese A ^a   Kosten, Thomas R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^c BEIJING HUILONGGUAN HOSPITAL   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

^e PEKING UNIVERSITY   (China)

Author keywords

Antipsychotic; Association; BDNF; Genotype; Schizophrenia; Weight gain

Indexed keywords

ANTIPARKINSON AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LITHIUM; METHIONINE; NEUROLEPTIC AGENT; PERPHENAZINE; RISPERIDONE; TRIFLUOPERAZINE; VALINE; VALPROIC ACID;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLISM; MONOTHERAPY; PRIORITY JOURNAL; SCHIZOPHRENIA; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHRONIC DISEASE; FEMALE; GENOTYPE; HUMANS; INPATIENTS; MALE; METHIONINE; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SEX FACTORS; VALINE; WEIGHT GAIN;

EID: 47249138191     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301619     Document Type: Article

References (33)

1. Allison DB, Casey DE (2001). Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 62(Suppl 7): 22-31.
2. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC et al (1999). Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686-1696.
3. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, American Psychiatric Association, Washington, D.C.
4. Angelucci F, Mathe AA, Aloe L (2000). Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J Neurosci Res 60: 783-794.
5. Baptista T (1999). Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand 100: 3-16.
6. Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL (2001). Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry 62(Suppl 23): 45-66.
7. Blackburn GL (2000). Weight gain and antipsychotic medication. J Clin Psychiatry 61(Suppl 8): 36-41.
8. Correll CU, Malhotra AK (2004). Pharmacogenetics of antipsychotic-induced weight gain. Psychopharmacology 174: 477-489.
9. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
10. Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P (1999). The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med 245: 253-259.
11. Hinney A, Hohmann S, Geller F, Vogel C, Hess C, Wermter AK et al (2003). Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 88: 4258-4267.
12. Karege F, Schwald M, Cisse M (2002). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets, Neurosci. Lett 328: 261-264.
13. Kernie SG, Liebl DJ, Parada LF (2000). BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19: 1290-1300.
14. Lipska BK, Khaing ZZ, Weickert CS, Weinberger DR (2001). BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur J Neurosci 14: 135-144.
15. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH (1999). Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96: 15239-15244.
16. Nakagawa T, Tsuchida A, Itakura Y, Nonomura T, Ono M, Hirota F et al (2000). Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 49: 436-444.
17. Nasrallah H (2003). A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 28(Suppl 1): 83-96.
18. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL (2002). The brain derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71: 651-655.
19. Nonomura T, Tsuchida A, Ono-Kishino M, Nakagawa T, Taiji M, Noguchi H (2001). Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice. Int J Exp Diabetes Res 2: 201-209.
20. Ono M, Ichihara J, Nonomura T, Itakura Y, Taiji M, Nakayama C et al (1997). Brain derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun 238: 633-637.
21. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998). Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37: 1553-1561.
22. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T et al (1995). Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543.
23. Reynolds GP, Templeman LA, Zhang ZJ (2005). The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antiphsychotic drug treatment. Prog Neuropsychopharmacol Biol Psychiatry 29: 1021-1028.
24. Reynolds GP, Zhang ZJ, Zhang XB (2002). Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359: 2086-2087.
25. Ribases M, Gratacos M, Armengol L, de Cid R, Badia A, Jimenez L et al (2003). Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry 8: 745-751.
26. Ribases M, Gratacos M, Fernandez-Aranda F, Bellodi L, Boni C, Anderluh M et al (2004). Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet 13: 1205-1212.
27. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R et al (2001). Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15: 1748-1757.
28. Tan YL, Zhou DF, Cao LY, Zou YZ, Zhang XY (2005a). Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci Lett 382: 27-32.
29. Tan YL, Zhou DF, Zhang XY (2005b). Decreased plasma brain derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr Res 74: 263-270.
30. Taylor DM, McAskill R (2000). Atypical antipsychotics and weight gain - a systematic review. Acta Psychiatr Scand 101: 416-432.
31. Tsuchida A, Nonomura T, Ono-Kishino M, Nakagawa T, Taiji M, Noguchi H (2001). Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int J Obes Relat Metab Disord 25: 1286-1293.
32. Werneke U, Taylor D, Sanders TA (2002). Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int Clin Psychopharmacol 17: 145-160.
33. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR et al (2003). Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6: 736-742.